Stay updated on Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page footer version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site/software update rather than a change to the clinical study information.
    Difference
    0.1%
    Check dated 2026-04-25T18:40:40.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision: v3.5.2 updated from v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T13:34:55.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    No substantive changes detected in the study record; the study details and eligibility criteria appear unchanged.
    Difference
    0.1%
    Check dated 2026-04-11T10:40:56.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision: v3.5.0 updated from the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T01:06:44.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-06T18:40:03.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    No additions or deletions to core study information were observed; the page content remains unchanged aside from minor UI/metadata adjustments.
    Difference
    0.1%
    Check dated 2026-02-27T18:51:03.000Z thumbnail image

Stay in the know with updates to Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial page.